BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21786480)

  • 1. [Revised Surviving Sepsis Campaign Guidelines and therapy for severe sepsis].
    Aikawa N
    Jpn J Antibiot; 2011 Feb; 64(1):37-44. PubMed ID: 21786480
    [No Abstract]   [Full Text] [Related]  

  • 2. A campaign worth joining: improving outcome in severe sepsis and septic shock using the Surviving Sepsis Campaign guidelines.
    Patel GP; Elpern EH; Balk RA
    South Med J; 2007 Jun; 100(6):557-8. PubMed ID: 17591307
    [No Abstract]   [Full Text] [Related]  

  • 3. Definitions and pathophysiology of sepsis.
    Sagy M; Al-Qaqaa Y; Kim P
    Curr Probl Pediatr Adolesc Health Care; 2013; 43(10):260-3. PubMed ID: 24295606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
    Voves C; Wuillemin WA; Zeerleder S
    Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pentoxifylline on coagulation profile and disseminated intravascular coagulation incidence in Egyptian septic neonates.
    Adel M; Awad HA; Abdel-Naim AB; Al-Azizi MM
    J Clin Pharm Ther; 2010 Jun; 35(3):257-65. PubMed ID: 20831528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognizing and managing severe sepsis: a common and deadly threat.
    Schlichting D; McCollam JS
    South Med J; 2007 Jun; 100(6):594-600. PubMed ID: 17591313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
    Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
    Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surviving sepsis: the role of the nurse.
    Dellacroce H
    RN; 2009 Jul; 72(7):16-21. PubMed ID: 19650228
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated nucleosome levels in systemic inflammation and sepsis.
    Zeerleder S; Zwart B; Wuillemin WA; Aarden LA; Groeneveld AB; Caliezi C; van Nieuwenhuijze AE; van Mierlo GJ; Eerenberg AJ; Lämmle B; Hack CE
    Crit Care Med; 2003 Jul; 31(7):1947-51. PubMed ID: 12847387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interpretation on the "surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children"].
    Zhang XP; Ji Y; Chen SY
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Apr; 22(4):305-309. PubMed ID: 32312366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?
    Dremsizov T; Clermont G; Kellum JA; Kalassian KG; Fine MJ; Angus DC
    Chest; 2006 Apr; 129(4):968-78. PubMed ID: 16608946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe sepsis and septic shock].
    Tønnesen E; Larsen K
    Ugeskr Laeger; 2014 Jul; 176(28):V03130200. PubMed ID: 25292001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review.
    Bochud PY; Bonten M; Marchetti O; Calandra T
    Crit Care Med; 2004 Nov; 32(11 Suppl):S495-512. PubMed ID: 15542958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disseminated intravascular coagulation and sepsis].
    Sevcík P; Matýsková M; Penka M; Táborská D
    Vnitr Lek; 1991 May; 37(5):514-7. PubMed ID: 1842151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic plasma exchange in severe sepsis or septic shock.
    Kes P
    Acta Med Croatica; 1998; 52(2):127-32. PubMed ID: 9682501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit by Okabayashi et al.
    Zeerleder S; Voves C; Wuillemin WA
    Am J Hematol; 2005 Aug; 79(4):344. PubMed ID: 16044451
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sepsis and multi-organ failure].
    Okajima K
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():319-24. PubMed ID: 12717991
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospectively validated predictions of shock and organ failure in individual septic surgical patients: the Systemic Mediator Associated Response Test.
    Slotman GJ
    Crit Care; 2000; 4(5):319-26. PubMed ID: 11056759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing mortality in severe sepsis and septic shock.
    Levinson AT; Casserly BP; Levy MM
    Semin Respir Crit Care Med; 2011 Apr; 32(2):195-205. PubMed ID: 21506056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.